Maria J. Pareja

Sevilla, AN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.

Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.

Journal: Gut

Published: August 01, 2023

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.

Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.

Journal: United European gastroenterology journal

Published: July 17, 2023

Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.

Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non-Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers.

Journal: JCO precision oncology

Published: March 02, 2023

miR-21-5p promotes NASH-related hepatocarcinogenesis.

miR-21-5p promotes NASH-related hepatocarcinogenesis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 27, 2023

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.

Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective.

Journal: Expert review of pharmacoeconomics & outcomes research

Published: May 20, 2022

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.

The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma.

Journal: EBioMedicine

Published: July 27, 2021

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.

Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System.

Journal: Journal of personalized medicine

Published: April 22, 2021

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.

Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD.

Journal: Frontiers in medicine

Published: March 20, 2021

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.

Journal: Journal of hepatology

Published: August 14, 2020

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Journal: Gut

Published: July 23, 2020

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.

RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease.

Journal: Gut

Published: May 09, 2020

Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.

Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH.

Journal: Gastroenterologia y hepatologia

Published: August 31, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026